Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2026-04-13 @ 1:52 PM
Study NCT ID:
NCT07264634
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-04
First Post:
2025-11-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide)
Sponsor:
Ascendis Pharma A/S
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ASND0044
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None